Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lipella Pharmaceuticals Inc

2.59
-0.0100-0.38%
Volume:18.12K
Turnover:45.94K
Market Cap:3.13M
PE:-0.58
High:2.60
Open:2.54
Low:2.45
Close:2.60
Loading ...

Lipella Pharmaceuticals Granted FDA Approval for Expanded Access Program for Lp-310 in Oral Lichen Planus

THOMSON REUTERS
·
06 Feb

Lipella Pharmaceuticals Granted FDA Approval for Expanded Access Program for LP-310 in Oral Lichen Planus

GlobeNewswire
·
06 Feb

Spartan Capital Securities, Llc Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.’s $875,500 Private Placement

THOMSON REUTERS
·
11 Jan

Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.’s $875,500 Private Placement

GlobeNewswire
·
11 Jan

Lipella Pharmaceuticals announces publication in CUREUS

TIPRANKS
·
03 Dec 2024

Lipella Pharmaceuticals Announces Publication in Cureus on Non-Steroid Treatment of Oral Lichen Planus

THOMSON REUTERS
·
03 Dec 2024

BUZZ-Lipella rises after completing dosing of patient group in drug trial

Reuters
·
22 Nov 2024

BRIEF-Lipella Pharmaceuticals Announces Completion of First Cohort in Phase 2a Trial of LP-310

Reuters
·
21 Nov 2024

Lipella Pharmaceuticals Announces Completion of First Cohort in Phase 2a Trial of Lp-310 for Oral Lichen Planus, Advancing to Next Dose Group

THOMSON REUTERS
·
21 Nov 2024

Lipella Pharmaceuticals Inc - Trial Expected to Conclude by Mid-2025 With Top-Line Data by Year-End 2024

THOMSON REUTERS
·
21 Nov 2024

Maxim Group Keeps Their Buy Rating on Lipella Pharmaceuticals, Inc. (LIPO)

TIPRANKS
·
20 Nov 2024

Lipella Pharmaceuticals Third Quarter 2024 Earnings: US$1.29 loss per share (vs US$1.84 loss in 3Q 2023)

Simply Wall St.
·
17 Nov 2024

Lipella Pharmaceuticals Faces Nasdaq Delisting Risk Amid Compliance Challenges

TIPRANKS
·
16 Nov 2024

Lipella Pharmaceuticals announces 1-for-8 reverse stock split

TIPRANKS
·
02 Nov 2024

Lipella Pharmaceuticals Inc - Reverse Stock Split to Comply With Nasdaq Minimum Bid Price Requirement

THOMSON REUTERS
·
02 Nov 2024

Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock Split

GlobeNewswire
·
02 Nov 2024